RecruitingNCT07454135

Mechanisms of Atrial Pathoelectrophysiology in HCM

Sponsor

Guy's and St Thomas' NHS Foundation Trust

Enrollment

40 participants

Start Date

May 26, 2026

Study Type

OBSERVATIONAL

Conditions

Hypertrophic Cardiomyopathy (HCM)Atrial Fibrillation (AF)

Summary

This study aims to learn why atrial fibrillation (AF), a type of irregular heartbeat, happens more often and is harder to treat in people with hypertrophic cardiomyopathy (HCM). HCM is an inherited condition where the heart muscle is thicker than usual. Researchers will study electrical signals from the heart and advanced heart imaging. By doing this, they hope to better understand how AF behaves in people with HCM and why treatments may not work as well for them. The information from this study may help improve future treatments for people who have both HCM and AF.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with atrial fibrillation (af) and hypertrophic cardiomyopathy (hcm). The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.